Related by context. Frequent words. (Click for all words.) 81 Phase 2b study 81 Phase IIb trial 80 Phase Ib 79 Phase IIa trial 78 Phase IIb 78 Phase 2a clinical 78 Phase 2b clinical 78 Phase 2a 78 Phase 1b 77 Phase IIb clinical 77 Phase III 77 pivotal Phase III 76 Phase 2b 76 Phase IIa clinical 76 Phase IIa 75 Phase III clinical 73 Phase III trials 73 clinical trial 72 pivotal Phase 72 dose escalation study 72 Phase III clinical trials 71 Phase II 69 randomized Phase 68 dose escalation 67 placebo controlled 67 RG# [001] 67 mipomersen 67 ofatumumab 66 PRX # 66 clinical trials 66 double blind placebo 66 INCB# [002] 65 IMGN# 65 multicenter 65 randomized placebo controlled 65 investigational compound 64 HspE7 64 MGCD# [001] 64 ISIS # 64 AP# [003] 63 Phase 63 FOLOTYN 63 tolerability 63 CRx 63 tivozanib 63 blind randomized placebo 63 relapsing remitting multiple sclerosis 63 Marqibo 62 daclizumab 62 T DM1 62 randomized double 62 IDX# 62 RDEA# 62 LymphoStat B 62 voreloxin 62 oral formulation 62 investigational drug 62 perifosine 62 NDA submission 61 XL# [003] 61 carfilzomib 61 Zenvia 61 ASA# 61 pharmacokinetic 61 pralatrexate 61 linaclotide 61 initiate Phase 61 Santhera 61 picoplatin 61 randomized controlled 61 hormone refractory prostate cancer 61 AZD# 60 IND enabling 60 eculizumab 60 lubiprostone 60 preclinical 60 randomized clinical 59 Locteron 59 multicenter study 59 preclinical studies 59 LEVADEX 59 panitumumab 59 monotherapy 59 sunitinib 59 prospective randomized 59 temozolomide 59 satraplatin 58 tolerability profile 58 Iluvien 58 dosing regimens 58 pharmacokinetic profile 58 unblinded 58 CYT# 58 safety tolerability 58 AMR# 58 MDV# 58 BiovaxID 58 ARRY 58 midstage study 58 AEZS 58 Alpharadin